nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—hypertension—type 2 diabetes mellitus	0.365	1	CtDrD
Nicardipine—CALM1—type 2 diabetes mellitus	0.14	0.65	CbGaD
Nicardipine—CYP2E1—type 2 diabetes mellitus	0.0463	0.215	CbGaD
Nicardipine—CYP3A4—type 2 diabetes mellitus	0.0291	0.135	CbGaD
Nicardipine—ADRA1D—Bromocriptine—type 2 diabetes mellitus	0.0156	0.0619	CbGbCtD
Nicardipine—ADRA1B—Bromocriptine—type 2 diabetes mellitus	0.0114	0.045	CbGbCtD
Nicardipine—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.00983	0.0389	CbGbCtD
Nicardipine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.00898	0.0355	CbGbCtD
Nicardipine—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.00786	0.0311	CbGbCtD
Nicardipine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00746	0.0295	CbGbCtD
Nicardipine—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.00711	0.0281	CbGbCtD
Nicardipine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00701	0.0278	CbGbCtD
Nicardipine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.00685	0.0271	CbGbCtD
Nicardipine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00665	0.0263	CbGbCtD
Nicardipine—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.00656	0.026	CbGbCtD
Nicardipine—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.00633	0.0251	CbGbCtD
Nicardipine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.00627	0.0248	CbGbCtD
Nicardipine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00596	0.0236	CbGbCtD
Nicardipine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00596	0.0236	CbGbCtD
Nicardipine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.00583	0.0231	CbGbCtD
Nicardipine—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0056	0.0222	CbGbCtD
Nicardipine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0055	0.0218	CbGbCtD
Nicardipine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00531	0.021	CbGbCtD
Nicardipine—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00516	0.0204	CbGbCtD
Nicardipine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00496	0.0196	CbGbCtD
Nicardipine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00496	0.0196	CbGbCtD
Nicardipine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00481	0.019	CbGbCtD
Nicardipine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.00457	0.0181	CbGbCtD
Nicardipine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00453	0.0179	CbGbCtD
Nicardipine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00447	0.0177	CbGbCtD
Nicardipine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00442	0.0175	CbGbCtD
Nicardipine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00418	0.0166	CbGbCtD
Nicardipine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00404	0.016	CbGbCtD
Nicardipine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00399	0.0158	CbGbCtD
Nicardipine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00376	0.0149	CbGbCtD
Nicardipine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00365	0.0144	CbGbCtD
Nicardipine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0036	0.0143	CbGbCtD
Nicardipine—CYP3A5—Losartan—type 2 diabetes mellitus	0.00346	0.0137	CbGbCtD
Nicardipine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00343	0.0136	CbGbCtD
Nicardipine—CYP2C8—Losartan—type 2 diabetes mellitus	0.00333	0.0132	CbGbCtD
Nicardipine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0033	0.0131	CbGbCtD
Nicardipine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00329	0.013	CbGbCtD
Nicardipine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00319	0.0126	CbGbCtD
Nicardipine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00305	0.0121	CbGbCtD
Nicardipine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00288	0.0114	CbGbCtD
Nicardipine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00279	0.011	CbGbCtD
Nicardipine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00254	0.01	CbGbCtD
Nicardipine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00246	0.00975	CbGbCtD
Nicardipine—CYP2C9—Losartan—type 2 diabetes mellitus	0.00232	0.00919	CbGbCtD
Nicardipine—ABCB1—Losartan—type 2 diabetes mellitus	0.00225	0.00891	CbGbCtD
Nicardipine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00218	0.00865	CbGbCtD
Nicardipine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00209	0.00829	CbGbCtD
Nicardipine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00209	0.00829	CbGbCtD
Nicardipine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00198	0.00784	CbGbCtD
Nicardipine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00148	0.00584	CbGbCtD
Nicardipine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00135	0.00534	CbGbCtD
Nicardipine—CALM1—sympathetic nervous system—type 2 diabetes mellitus	0.00128	0.0571	CbGeAlD
Nicardipine—CALM1—autonomic nervous system—type 2 diabetes mellitus	0.000861	0.0384	CbGeAlD
Nicardipine—CALM2—peripheral nervous system—type 2 diabetes mellitus	0.000624	0.0278	CbGeAlD
Nicardipine—CALM1—peripheral nervous system—type 2 diabetes mellitus	0.000621	0.0277	CbGeAlD
Nicardipine—CALM2—artery—type 2 diabetes mellitus	0.00049	0.0219	CbGeAlD
Nicardipine—CALM1—artery—type 2 diabetes mellitus	0.000488	0.0218	CbGeAlD
Nicardipine—CALM2—nerve—type 2 diabetes mellitus	0.000486	0.0217	CbGeAlD
Nicardipine—PDE1A—nephron tubule—type 2 diabetes mellitus	0.000485	0.0216	CbGeAlD
Nicardipine—CALM1—nerve—type 2 diabetes mellitus	0.000484	0.0216	CbGeAlD
Nicardipine—PDE1B—adipose tissue—type 2 diabetes mellitus	0.000458	0.0204	CbGeAlD
Nicardipine—CACNB2—islet of Langerhans—type 2 diabetes mellitus	0.000444	0.0198	CbGeAlD
Nicardipine—PDE1A—cardiovascular system—type 2 diabetes mellitus	0.000435	0.0194	CbGeAlD
Nicardipine—PDE1A—kidney—type 2 diabetes mellitus	0.000426	0.019	CbGeAlD
Nicardipine—PDE1A—cortex of kidney—type 2 diabetes mellitus	0.000415	0.0185	CbGeAlD
Nicardipine—CALM2—endothelium—type 2 diabetes mellitus	0.000414	0.0185	CbGeAlD
Nicardipine—CALM1—endothelium—type 2 diabetes mellitus	0.000412	0.0184	CbGeAlD
Nicardipine—CACNA1D—islet of Langerhans—type 2 diabetes mellitus	0.000388	0.0173	CbGeAlD
Nicardipine—PDE1A—adipose tissue—type 2 diabetes mellitus	0.000384	0.0171	CbGeAlD
Nicardipine—CACNB2—retina—type 2 diabetes mellitus	0.000379	0.0169	CbGeAlD
Nicardipine—CACNB2—cardiovascular system—type 2 diabetes mellitus	0.000321	0.0143	CbGeAlD
Nicardipine—CACNB2—cortex of kidney—type 2 diabetes mellitus	0.000306	0.0136	CbGeAlD
Nicardipine—CACNA2D1—cardiovascular system—type 2 diabetes mellitus	0.000301	0.0134	CbGeAlD
Nicardipine—CALM3—islet of Langerhans—type 2 diabetes mellitus	0.0003	0.0134	CbGeAlD
Nicardipine—CACNA1D—cardiovascular system—type 2 diabetes mellitus	0.000281	0.0125	CbGeAlD
Nicardipine—ADRA1B—kidney—type 2 diabetes mellitus	0.000278	0.0124	CbGeAlD
Nicardipine—CACNA1D—pancreas—type 2 diabetes mellitus	0.000273	0.0122	CbGeAlD
Nicardipine—PDE1A—liver—type 2 diabetes mellitus	0.000269	0.012	CbGeAlD
Nicardipine—CACNA2D1—adipose tissue—type 2 diabetes mellitus	0.000266	0.0119	CbGeAlD
Nicardipine—CACNA1C—cardiovascular system—type 2 diabetes mellitus	0.000259	0.0115	CbGeAlD
Nicardipine—CALM3—retina—type 2 diabetes mellitus	0.000256	0.0114	CbGeAlD
Nicardipine—CALM3—nephron tubule—type 2 diabetes mellitus	0.000242	0.0108	CbGeAlD
Nicardipine—CALM2—islet of Langerhans—type 2 diabetes mellitus	0.000236	0.0105	CbGeAlD
Nicardipine—CALM1—islet of Langerhans—type 2 diabetes mellitus	0.000234	0.0105	CbGeAlD
Nicardipine—CACNA1C—adipose tissue—type 2 diabetes mellitus	0.000228	0.0102	CbGeAlD
Nicardipine—Felodipine—CALM1—type 2 diabetes mellitus	0.000219	0.122	CrCbGaD
Nicardipine—CHRM2—cardiovascular system—type 2 diabetes mellitus	0.000214	0.00953	CbGeAlD
Nicardipine—Nifedipine—CALM1—type 2 diabetes mellitus	0.000212	0.118	CrCbGaD
Nicardipine—CALM3—pancreas—type 2 diabetes mellitus	0.000211	0.0094	CbGeAlD
Nicardipine—CALM3—cortex of kidney—type 2 diabetes mellitus	0.000207	0.00922	CbGeAlD
Nicardipine—CALM2—retina—type 2 diabetes mellitus	0.000201	0.00898	CbGeAlD
Nicardipine—CALM1—retina—type 2 diabetes mellitus	0.0002	0.00894	CbGeAlD
Nicardipine—CACNB2—liver—type 2 diabetes mellitus	0.000199	0.00885	CbGeAlD
Nicardipine—CHRM1—cardiovascular system—type 2 diabetes mellitus	0.000194	0.00867	CbGeAlD
Nicardipine—CALM3—adipose tissue—type 2 diabetes mellitus	0.000191	0.00853	CbGeAlD
Nicardipine—CALM2—nephron tubule—type 2 diabetes mellitus	0.00019	0.00846	CbGeAlD
Nicardipine—CALM1—nephron tubule—type 2 diabetes mellitus	0.000189	0.00842	CbGeAlD
Nicardipine—CACNA2D1—liver—type 2 diabetes mellitus	0.000186	0.00831	CbGeAlD
Nicardipine—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000176	0.00786	CbGeAlD
Nicardipine—CACNA1D—liver—type 2 diabetes mellitus	0.000174	0.00774	CbGeAlD
Nicardipine—CALM2—cardiovascular system—type 2 diabetes mellitus	0.00017	0.0076	CbGeAlD
Nicardipine—CHRM3—kidney—type 2 diabetes mellitus	0.00017	0.00759	CbGeAlD
Nicardipine—CALM1—cardiovascular system—type 2 diabetes mellitus	0.00017	0.00756	CbGeAlD
Nicardipine—CALM2—kidney—type 2 diabetes mellitus	0.000167	0.00743	CbGeAlD
Nicardipine—CALM1—kidney—type 2 diabetes mellitus	0.000166	0.0074	CbGeAlD
Nicardipine—CALM2—pancreas—type 2 diabetes mellitus	0.000166	0.00738	CbGeAlD
Nicardipine—CALM1—pancreas—type 2 diabetes mellitus	0.000165	0.00735	CbGeAlD
Nicardipine—CALM2—cortex of kidney—type 2 diabetes mellitus	0.000162	0.00724	CbGeAlD
Nicardipine—CALM1—cortex of kidney—type 2 diabetes mellitus	0.000162	0.00721	CbGeAlD
Nicardipine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.00016	0.00713	CbGeAlD
Nicardipine—CHRM3—adipose tissue—type 2 diabetes mellitus	0.000153	0.00684	CbGeAlD
Nicardipine—CALM2—adipose tissue—type 2 diabetes mellitus	0.00015	0.0067	CbGeAlD
Nicardipine—CALM1—adipose tissue—type 2 diabetes mellitus	0.00015	0.00667	CbGeAlD
Nicardipine—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000142	0.00633	CbGeAlD
Nicardipine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000141	0.00629	CbGeAlD
Nicardipine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000141	0.00628	CbGeAlD
Nicardipine—CYP2C8—kidney—type 2 diabetes mellitus	0.000138	0.00616	CbGeAlD
Nicardipine—CALM3—liver—type 2 diabetes mellitus	0.000134	0.00598	CbGeAlD
Nicardipine—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000132	0.0059	CbGeAlD
Nicardipine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000127	0.00565	CbGeAlD
Nicardipine—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000125	0.00559	CbGeAlD
Nicardipine—CYP3A5—kidney—type 2 diabetes mellitus	0.000125	0.00556	CbGeAlD
Nicardipine—CYP2B6—kidney—type 2 diabetes mellitus	0.000124	0.00553	CbGeAlD
Nicardipine—CYP3A5—pancreas—type 2 diabetes mellitus	0.000124	0.00552	CbGeAlD
Nicardipine—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000121	0.00542	CbGeAlD
Nicardipine—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000119	0.0053	CbGeAlD
Nicardipine—CYP2E1—kidney—type 2 diabetes mellitus	0.000116	0.00519	CbGeAlD
Nicardipine—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000113	0.00505	CbGeAlD
Nicardipine—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000112	0.00501	CbGeAlD
Nicardipine—CALM2—liver—type 2 diabetes mellitus	0.000105	0.0047	CbGeAlD
Nicardipine—CALM1—liver—type 2 diabetes mellitus	0.000105	0.00468	CbGeAlD
Nicardipine—Clevidipine—CYP2E1—type 2 diabetes mellitus	0.000101	0.0563	CrCbGaD
Nicardipine—CYP2C19—liver—type 2 diabetes mellitus	0.0001	0.00446	CbGeAlD
Nicardipine—Nifedipine—ABCC2—type 2 diabetes mellitus	9.96e-05	0.0554	CrCbGaD
Nicardipine—ADRA1A—liver—type 2 diabetes mellitus	9.88e-05	0.00441	CbGeAlD
Nicardipine—Clevidipine—CYP1A2—type 2 diabetes mellitus	9.63e-05	0.0536	CrCbGaD
Nicardipine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	9.36e-05	0.00417	CbGeAlD
Nicardipine—CYP3A4—kidney—type 2 diabetes mellitus	9.36e-05	0.00417	CbGeAlD
Nicardipine—Nisoldipine—CYP1A2—type 2 diabetes mellitus	9.24e-05	0.0514	CrCbGaD
Nicardipine—CYP2D6—kidney—type 2 diabetes mellitus	9.21e-05	0.00411	CbGeAlD
Nicardipine—Nilvadipine—CYP2E1—type 2 diabetes mellitus	9.08e-05	0.0505	CrCbGaD
Nicardipine—CYP2C8—liver—type 2 diabetes mellitus	8.73e-05	0.00389	CbGeAlD
Nicardipine—Nilvadipine—CYP1A2—type 2 diabetes mellitus	8.64e-05	0.0481	CrCbGaD
Nicardipine—Lercanidipine—CYP3A4—type 2 diabetes mellitus	8.01e-05	0.0446	CrCbGaD
Nicardipine—ABCB1—retina—type 2 diabetes mellitus	8e-05	0.00357	CbGeAlD
Nicardipine—CYP3A5—liver—type 2 diabetes mellitus	7.88e-05	0.00351	CbGeAlD
Nicardipine—CYP2B6—liver—type 2 diabetes mellitus	7.83e-05	0.00349	CbGeAlD
Nicardipine—CYP2C9—liver—type 2 diabetes mellitus	7.76e-05	0.00346	CbGeAlD
Nicardipine—ABCB1—nephron tubule—type 2 diabetes mellitus	7.54e-05	0.00336	CbGeAlD
Nicardipine—Amlodipine—CYP1A2—type 2 diabetes mellitus	7.44e-05	0.0414	CrCbGaD
Nicardipine—CYP2E1—liver—type 2 diabetes mellitus	7.35e-05	0.00328	CbGeAlD
Nicardipine—Isradipine—CYP3A4—type 2 diabetes mellitus	7.24e-05	0.0403	CrCbGaD
Nicardipine—Loss of consciousness—Metformin—type 2 diabetes mellitus	7.06e-05	0.000964	CcSEcCtD
Nicardipine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	7.05e-05	0.000963	CcSEcCtD
Nicardipine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.03e-05	0.000961	CcSEcCtD
Nicardipine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	7.03e-05	0.00096	CcSEcCtD
Nicardipine—Tension—Losartan—type 2 diabetes mellitus	7e-05	0.000956	CcSEcCtD
Nicardipine—Dizziness—Glimepiride—type 2 diabetes mellitus	6.99e-05	0.000955	CcSEcCtD
Nicardipine—Nifedipine—CYP2E1—type 2 diabetes mellitus	6.99e-05	0.0389	CrCbGaD
Nicardipine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	6.98e-05	0.000954	CcSEcCtD
Nicardipine—Dizziness—Sitagliptin—type 2 diabetes mellitus	6.97e-05	0.000952	CcSEcCtD
Nicardipine—Agitation—Irbesartan—type 2 diabetes mellitus	6.96e-05	0.000951	CcSEcCtD
Nicardipine—Somnolence—Gliclazide—type 2 diabetes mellitus	6.96e-05	0.000951	CcSEcCtD
Nicardipine—Hypertension—Metformin—type 2 diabetes mellitus	6.93e-05	0.000947	CcSEcCtD
Nicardipine—Nervousness—Losartan—type 2 diabetes mellitus	6.93e-05	0.000946	CcSEcCtD
Nicardipine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	6.92e-05	0.000945	CcSEcCtD
Nicardipine—Abdominal pain—Glyburide—type 2 diabetes mellitus	6.9e-05	0.000942	CcSEcCtD
Nicardipine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000942	CcSEcCtD
Nicardipine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	6.87e-05	0.000939	CcSEcCtD
Nicardipine—Asthenia—Bromocriptine—type 2 diabetes mellitus	6.85e-05	0.000935	CcSEcCtD
Nicardipine—Chest pain—Metformin—type 2 diabetes mellitus	6.84e-05	0.000934	CcSEcCtD
Nicardipine—Myalgia—Metformin—type 2 diabetes mellitus	6.84e-05	0.000934	CcSEcCtD
Nicardipine—Malaise—Irbesartan—type 2 diabetes mellitus	6.83e-05	0.000933	CcSEcCtD
Nicardipine—Vertigo—Irbesartan—type 2 diabetes mellitus	6.81e-05	0.00093	CcSEcCtD
Nicardipine—Headache—Pioglitazone—type 2 diabetes mellitus	6.8e-05	0.000929	CcSEcCtD
Nicardipine—Syncope—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000928	CcSEcCtD
Nicardipine—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.77e-05	0.00302	CbGeAlD
Nicardipine—Visual impairment—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000925	CcSEcCtD
Nicardipine—Discomfort—Metformin—type 2 diabetes mellitus	6.75e-05	0.000923	CcSEcCtD
Nicardipine—Nausea—Glipizide—type 2 diabetes mellitus	6.73e-05	0.00092	CcSEcCtD
Nicardipine—Vomiting—Glimepiride—type 2 diabetes mellitus	6.73e-05	0.000919	CcSEcCtD
Nicardipine—Hypotension—Valsartan—type 2 diabetes mellitus	6.72e-05	0.000919	CcSEcCtD
Nicardipine—Vision blurred—Losartan—type 2 diabetes mellitus	6.72e-05	0.000918	CcSEcCtD
Nicardipine—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.7e-05	0.000916	CcSEcCtD
Nicardipine—Constipation—Gliclazide—type 2 diabetes mellitus	6.7e-05	0.000915	CcSEcCtD
Nicardipine—Pain—Gliclazide—type 2 diabetes mellitus	6.7e-05	0.000915	CcSEcCtD
Nicardipine—Tremor—Losartan—type 2 diabetes mellitus	6.68e-05	0.000913	CcSEcCtD
Nicardipine—Rash—Glimepiride—type 2 diabetes mellitus	6.67e-05	0.000911	CcSEcCtD
Nicardipine—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.66e-05	0.00091	CcSEcCtD
Nicardipine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	6.66e-05	0.00091	CcSEcCtD
Nicardipine—Nifedipine—CYP1A2—type 2 diabetes mellitus	6.65e-05	0.037	CrCbGaD
Nicardipine—Rash—Sitagliptin—type 2 diabetes mellitus	6.65e-05	0.000908	CcSEcCtD
Nicardipine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.64e-05	0.000907	CcSEcCtD
Nicardipine—Headache—Glimepiride—type 2 diabetes mellitus	6.63e-05	0.000905	CcSEcCtD
Nicardipine—ABCB1—kidney—type 2 diabetes mellitus	6.62e-05	0.00295	CbGeAlD
Nicardipine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	6.62e-05	0.000904	CcSEcCtD
Nicardipine—Headache—Sitagliptin—type 2 diabetes mellitus	6.61e-05	0.000902	CcSEcCtD
Nicardipine—ABCB1—pancreas—type 2 diabetes mellitus	6.58e-05	0.00293	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.56e-05	0.000896	CcSEcCtD
Nicardipine—Agitation—Losartan—type 2 diabetes mellitus	6.55e-05	0.000895	CcSEcCtD
Nicardipine—Oedema—Metformin—type 2 diabetes mellitus	6.55e-05	0.000895	CcSEcCtD
Nicardipine—Tinnitus—Ramipril—type 2 diabetes mellitus	6.55e-05	0.000895	CcSEcCtD
Nicardipine—Hypertension—Irbesartan—type 2 diabetes mellitus	6.54e-05	0.000894	CcSEcCtD
Nicardipine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.53e-05	0.000892	CcSEcCtD
Nicardipine—Flushing—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000891	CcSEcCtD
Nicardipine—Infection—Metformin—type 2 diabetes mellitus	6.51e-05	0.000889	CcSEcCtD
Nicardipine—Insomnia—Valsartan—type 2 diabetes mellitus	6.51e-05	0.000889	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.48e-05	0.000885	CcSEcCtD
Nicardipine—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.46e-05	0.000883	CcSEcCtD
Nicardipine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.45e-05	0.000882	CcSEcCtD
Nicardipine—Myalgia—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000881	CcSEcCtD
Nicardipine—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000881	CcSEcCtD
Nicardipine—Chest pain—Irbesartan—type 2 diabetes mellitus	6.45e-05	0.000881	CcSEcCtD
Nicardipine—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.45e-05	0.00288	CbGeAlD
Nicardipine—Shock—Metformin—type 2 diabetes mellitus	6.45e-05	0.000881	CcSEcCtD
Nicardipine—Insomnia—Orlistat—type 2 diabetes mellitus	6.43e-05	0.000879	CcSEcCtD
Nicardipine—Malaise—Losartan—type 2 diabetes mellitus	6.43e-05	0.000878	CcSEcCtD
Nicardipine—Anxiety—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000878	CcSEcCtD
Nicardipine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.43e-05	0.000878	CcSEcCtD
Nicardipine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.42e-05	0.000877	CcSEcCtD
Nicardipine—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000876	CcSEcCtD
Nicardipine—Vertigo—Losartan—type 2 diabetes mellitus	6.41e-05	0.000875	CcSEcCtD
Nicardipine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.41e-05	0.000875	CcSEcCtD
Nicardipine—Somnolence—Valsartan—type 2 diabetes mellitus	6.4e-05	0.000874	CcSEcCtD
Nicardipine—Syncope—Losartan—type 2 diabetes mellitus	6.4e-05	0.000874	CcSEcCtD
Nicardipine—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.39e-05	0.000872	CcSEcCtD
Nicardipine—Clevidipine—CYP3A4—type 2 diabetes mellitus	6.38e-05	0.0355	CrCbGaD
Nicardipine—Discomfort—Irbesartan—type 2 diabetes mellitus	6.37e-05	0.000871	CcSEcCtD
Nicardipine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.34e-05	0.000865	CcSEcCtD
Nicardipine—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000865	CcSEcCtD
Nicardipine—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.31e-05	0.000862	CcSEcCtD
Nicardipine—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.31e-05	0.000862	CcSEcCtD
Nicardipine—Palpitations—Losartan—type 2 diabetes mellitus	6.3e-05	0.000861	CcSEcCtD
Nicardipine—Nausea—Glimepiride—type 2 diabetes mellitus	6.28e-05	0.000858	CcSEcCtD
Nicardipine—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.27e-05	0.000856	CcSEcCtD
Nicardipine—Nausea—Sitagliptin—type 2 diabetes mellitus	6.26e-05	0.000856	CcSEcCtD
Nicardipine—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.26e-05	0.000855	CcSEcCtD
Nicardipine—Asthenia—Glyburide—type 2 diabetes mellitus	6.26e-05	0.000855	CcSEcCtD
Nicardipine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.19e-05	0.000846	CcSEcCtD
Nicardipine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.19e-05	0.000846	CcSEcCtD
Nicardipine—Oedema—Irbesartan—type 2 diabetes mellitus	6.18e-05	0.000845	CcSEcCtD
Nicardipine—Constipation—Valsartan—type 2 diabetes mellitus	6.15e-05	0.000841	CcSEcCtD
Nicardipine—Infection—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000839	CcSEcCtD
Nicardipine—Hypotension—Metformin—type 2 diabetes mellitus	6.12e-05	0.000837	CcSEcCtD
Nicardipine—Nisoldipine—CYP3A4—type 2 diabetes mellitus	6.11e-05	0.034	CrCbGaD
Nicardipine—Shock—Irbesartan—type 2 diabetes mellitus	6.08e-05	0.000831	CcSEcCtD
Nicardipine—Pain—Orlistat—type 2 diabetes mellitus	6.08e-05	0.000831	CcSEcCtD
Nicardipine—Arthralgia—Losartan—type 2 diabetes mellitus	6.07e-05	0.000829	CcSEcCtD
Nicardipine—Chest pain—Losartan—type 2 diabetes mellitus	6.07e-05	0.000829	CcSEcCtD
Nicardipine—Myalgia—Losartan—type 2 diabetes mellitus	6.07e-05	0.000829	CcSEcCtD
Nicardipine—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.07e-05	0.000829	CcSEcCtD
Nicardipine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.06e-05	0.000827	CcSEcCtD
Nicardipine—Anxiety—Losartan—type 2 diabetes mellitus	6.05e-05	0.000826	CcSEcCtD
Nicardipine—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.04e-05	0.000825	CcSEcCtD
Nicardipine—Rash—Bromocriptine—type 2 diabetes mellitus	6.02e-05	0.000822	CcSEcCtD
Nicardipine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.01e-05	0.000821	CcSEcCtD
Nicardipine—Tension—Ramipril—type 2 diabetes mellitus	6e-05	0.00082	CcSEcCtD
Nicardipine—Discomfort—Losartan—type 2 diabetes mellitus	6e-05	0.000819	CcSEcCtD
Nicardipine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.98e-05	0.000817	CcSEcCtD
Nicardipine—Headache—Bromocriptine—type 2 diabetes mellitus	5.98e-05	0.000817	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.97e-05	0.000816	CcSEcCtD
Nicardipine—ABCB1—adipose tissue—type 2 diabetes mellitus	5.97e-05	0.00266	CbGeAlD
Nicardipine—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.97e-05	0.000815	CcSEcCtD
Nicardipine—Nervousness—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000811	CcSEcCtD
Nicardipine—Dry mouth—Losartan—type 2 diabetes mellitus	5.94e-05	0.000811	CcSEcCtD
Nicardipine—CYP3A4—liver—type 2 diabetes mellitus	5.91e-05	0.00264	CbGeAlD
Nicardipine—Nimodipine—CYP3A4—type 2 diabetes mellitus	5.91e-05	0.0329	CrCbGaD
Nicardipine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.88e-05	0.000804	CcSEcCtD
Nicardipine—Paraesthesia—Metformin—type 2 diabetes mellitus	5.88e-05	0.000804	CcSEcCtD
Nicardipine—Confusional state—Losartan—type 2 diabetes mellitus	5.87e-05	0.000802	CcSEcCtD
Nicardipine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.86e-05	0.0008	CcSEcCtD
Nicardipine—Dyspnoea—Metformin—type 2 diabetes mellitus	5.84e-05	0.000798	CcSEcCtD
Nicardipine—Somnolence—Metformin—type 2 diabetes mellitus	5.83e-05	0.000796	CcSEcCtD
Nicardipine—Oedema—Losartan—type 2 diabetes mellitus	5.82e-05	0.000795	CcSEcCtD
Nicardipine—CYP2D6—liver—type 2 diabetes mellitus	5.82e-05	0.0026	CbGeAlD
Nicardipine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.81e-05	0.000794	CcSEcCtD
Nicardipine—Infection—Losartan—type 2 diabetes mellitus	5.78e-05	0.00079	CcSEcCtD
Nicardipine—Hypotension—Irbesartan—type 2 diabetes mellitus	5.78e-05	0.000789	CcSEcCtD
Nicardipine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.77e-05	0.000788	CcSEcCtD
Nicardipine—Dyspepsia—Metformin—type 2 diabetes mellitus	5.77e-05	0.000788	CcSEcCtD
Nicardipine—Tremor—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000783	CcSEcCtD
Nicardipine—Shock—Losartan—type 2 diabetes mellitus	5.73e-05	0.000782	CcSEcCtD
Nicardipine—Nitrendipine—CYP3A4—type 2 diabetes mellitus	5.72e-05	0.0318	CrCbGaD
Nicardipine—Nilvadipine—CYP3A4—type 2 diabetes mellitus	5.72e-05	0.0318	CrCbGaD
Nicardipine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.7e-05	0.000778	CcSEcCtD
Nicardipine—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.69e-05	0.000777	CcSEcCtD
Nicardipine—Tachycardia—Losartan—type 2 diabetes mellitus	5.68e-05	0.000776	CcSEcCtD
Nicardipine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.67e-05	0.000775	CcSEcCtD
Nicardipine—Nausea—Bromocriptine—type 2 diabetes mellitus	5.67e-05	0.000774	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.00077	CcSEcCtD
Nicardipine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.63e-05	0.000769	CcSEcCtD
Nicardipine—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000768	CcSEcCtD
Nicardipine—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.62e-05	0.000768	CcSEcCtD
Nicardipine—Asthenia—Gliclazide—type 2 diabetes mellitus	5.62e-05	0.000768	CcSEcCtD
Nicardipine—Agitation—Ramipril—type 2 diabetes mellitus	5.62e-05	0.000768	CcSEcCtD
Nicardipine—Constipation—Metformin—type 2 diabetes mellitus	5.6e-05	0.000766	CcSEcCtD
Nicardipine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.55e-05	0.000759	CcSEcCtD
Nicardipine—Vomiting—Glyburide—type 2 diabetes mellitus	5.55e-05	0.000758	CcSEcCtD
Nicardipine—Malaise—Ramipril—type 2 diabetes mellitus	5.51e-05	0.000753	CcSEcCtD
Nicardipine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.51e-05	0.000753	CcSEcCtD
Nicardipine—Rash—Glyburide—type 2 diabetes mellitus	5.5e-05	0.000751	CcSEcCtD
Nicardipine—Somnolence—Irbesartan—type 2 diabetes mellitus	5.5e-05	0.000751	CcSEcCtD
Nicardipine—Dermatitis—Glyburide—type 2 diabetes mellitus	5.5e-05	0.000751	CcSEcCtD
Nicardipine—Vertigo—Ramipril—type 2 diabetes mellitus	5.49e-05	0.00075	CcSEcCtD
Nicardipine—Syncope—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000749	CcSEcCtD
Nicardipine—Headache—Glyburide—type 2 diabetes mellitus	5.46e-05	0.000746	CcSEcCtD
Nicardipine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000744	CcSEcCtD
Nicardipine—Hypotension—Losartan—type 2 diabetes mellitus	5.44e-05	0.000743	CcSEcCtD
Nicardipine—Palpitations—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000738	CcSEcCtD
Nicardipine—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.4e-05	0.000738	CcSEcCtD
Nicardipine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000734	CcSEcCtD
Nicardipine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.36e-05	0.000732	CcSEcCtD
Nicardipine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.36e-05	0.000732	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.3e-05	0.000724	CcSEcCtD
Nicardipine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.3e-05	0.000724	CcSEcCtD
Nicardipine—Constipation—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000722	CcSEcCtD
Nicardipine—Pain—Irbesartan—type 2 diabetes mellitus	5.29e-05	0.000722	CcSEcCtD
Nicardipine—Insomnia—Losartan—type 2 diabetes mellitus	5.26e-05	0.000719	CcSEcCtD
Nicardipine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.24e-05	0.000716	CcSEcCtD
Nicardipine—Paraesthesia—Losartan—type 2 diabetes mellitus	5.23e-05	0.000714	CcSEcCtD
Nicardipine—Myalgia—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000711	CcSEcCtD
Nicardipine—Arthralgia—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000711	CcSEcCtD
Nicardipine—Chest pain—Ramipril—type 2 diabetes mellitus	5.21e-05	0.000711	CcSEcCtD
Nicardipine—Dyspnoea—Losartan—type 2 diabetes mellitus	5.19e-05	0.000709	CcSEcCtD
Nicardipine—Anxiety—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000709	CcSEcCtD
Nicardipine—Nausea—Glyburide—type 2 diabetes mellitus	5.18e-05	0.000708	CcSEcCtD
Nicardipine—Abdominal pain—Metformin—type 2 diabetes mellitus	5.18e-05	0.000708	CcSEcCtD
Nicardipine—Dizziness—Gliclazide—type 2 diabetes mellitus	5.18e-05	0.000708	CcSEcCtD
Nicardipine—Somnolence—Losartan—type 2 diabetes mellitus	5.17e-05	0.000707	CcSEcCtD
Nicardipine—Asthenia—Valsartan—type 2 diabetes mellitus	5.16e-05	0.000705	CcSEcCtD
Nicardipine—Discomfort—Ramipril—type 2 diabetes mellitus	5.14e-05	0.000703	CcSEcCtD
Nicardipine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.12e-05	0.0007	CcSEcCtD
Nicardipine—Asthenia—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000697	CcSEcCtD
Nicardipine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000696	CcSEcCtD
Nicardipine—Dry mouth—Ramipril—type 2 diabetes mellitus	5.09e-05	0.000695	CcSEcCtD
Nicardipine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.06e-05	0.000691	CcSEcCtD
Nicardipine—Confusional state—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000687	CcSEcCtD
Nicardipine—Oedema—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000682	CcSEcCtD
Nicardipine—Vomiting—Gliclazide—type 2 diabetes mellitus	4.98e-05	0.00068	CcSEcCtD
Nicardipine—Pain—Losartan—type 2 diabetes mellitus	4.98e-05	0.00068	CcSEcCtD
Nicardipine—Constipation—Losartan—type 2 diabetes mellitus	4.98e-05	0.00068	CcSEcCtD
Nicardipine—Rash—Gliclazide—type 2 diabetes mellitus	4.94e-05	0.000675	CcSEcCtD
Nicardipine—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.93e-05	0.000674	CcSEcCtD
Nicardipine—Amlodipine—CYP3A4—type 2 diabetes mellitus	4.92e-05	0.0274	CrCbGaD
Nicardipine—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000673	CcSEcCtD
Nicardipine—Shock—Ramipril—type 2 diabetes mellitus	4.91e-05	0.000671	CcSEcCtD
Nicardipine—Headache—Gliclazide—type 2 diabetes mellitus	4.91e-05	0.00067	CcSEcCtD
Nicardipine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000668	CcSEcCtD
Nicardipine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.89e-05	0.000668	CcSEcCtD
Nicardipine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.89e-05	0.000667	CcSEcCtD
Nicardipine—Tachycardia—Ramipril—type 2 diabetes mellitus	4.87e-05	0.000665	CcSEcCtD
Nicardipine—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.87e-05	0.000665	CcSEcCtD
Nicardipine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000659	CcSEcCtD
Nicardipine—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.8e-05	0.000655	CcSEcCtD
Nicardipine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.76e-05	0.00065	CcSEcCtD
Nicardipine—Dizziness—Valsartan—type 2 diabetes mellitus	4.76e-05	0.00065	CcSEcCtD
Nicardipine—Dizziness—Orlistat—type 2 diabetes mellitus	4.7e-05	0.000642	CcSEcCtD
Nicardipine—Asthenia—Metformin—type 2 diabetes mellitus	4.7e-05	0.000642	CcSEcCtD
Nicardipine—Hypotension—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000637	CcSEcCtD
Nicardipine—Nausea—Gliclazide—type 2 diabetes mellitus	4.65e-05	0.000636	CcSEcCtD
Nicardipine—Body temperature increased—Losartan—type 2 diabetes mellitus	4.6e-05	0.000628	CcSEcCtD
Nicardipine—Abdominal pain—Losartan—type 2 diabetes mellitus	4.6e-05	0.000628	CcSEcCtD
Nicardipine—Vomiting—Valsartan—type 2 diabetes mellitus	4.58e-05	0.000625	CcSEcCtD
Nicardipine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.56e-05	0.000622	CcSEcCtD
Nicardipine—Felodipine—CYP3A4—type 2 diabetes mellitus	4.55e-05	0.0253	CrCbGaD
Nicardipine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000621	CcSEcCtD
Nicardipine—Rash—Valsartan—type 2 diabetes mellitus	4.54e-05	0.00062	CcSEcCtD
Nicardipine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.53e-05	0.000619	CcSEcCtD
Nicardipine—Vomiting—Orlistat—type 2 diabetes mellitus	4.52e-05	0.000618	CcSEcCtD
Nicardipine—Insomnia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000617	CcSEcCtD
Nicardipine—Headache—Valsartan—type 2 diabetes mellitus	4.51e-05	0.000616	CcSEcCtD
Nicardipine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.48e-05	0.000613	CcSEcCtD
Nicardipine—Rash—Orlistat—type 2 diabetes mellitus	4.48e-05	0.000612	CcSEcCtD
Nicardipine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.48e-05	0.000612	CcSEcCtD
Nicardipine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.48e-05	0.000612	CcSEcCtD
Nicardipine—Headache—Orlistat—type 2 diabetes mellitus	4.45e-05	0.000609	CcSEcCtD
Nicardipine—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000608	CcSEcCtD
Nicardipine—Asthenia—Irbesartan—type 2 diabetes mellitus	4.44e-05	0.000606	CcSEcCtD
Nicardipine—Somnolence—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000606	CcSEcCtD
Nicardipine—Nifedipine—CYP3A4—type 2 diabetes mellitus	4.4e-05	0.0245	CrCbGaD
Nicardipine—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.39e-05	0.0006	CcSEcCtD
Nicardipine—Dizziness—Metformin—type 2 diabetes mellitus	4.33e-05	0.000592	CcSEcCtD
Nicardipine—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.29e-05	0.000586	CcSEcCtD
Nicardipine—Nausea—Valsartan—type 2 diabetes mellitus	4.27e-05	0.000584	CcSEcCtD
Nicardipine—Constipation—Ramipril—type 2 diabetes mellitus	4.27e-05	0.000583	CcSEcCtD
Nicardipine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000578	CcSEcCtD
Nicardipine—Nausea—Orlistat—type 2 diabetes mellitus	4.22e-05	0.000577	CcSEcCtD
Nicardipine—ABCB1—liver—type 2 diabetes mellitus	4.19e-05	0.00187	CbGeAlD
Nicardipine—Asthenia—Losartan—type 2 diabetes mellitus	4.18e-05	0.00057	CcSEcCtD
Nicardipine—Vomiting—Metformin—type 2 diabetes mellitus	4.17e-05	0.000569	CcSEcCtD
Nicardipine—Rash—Metformin—type 2 diabetes mellitus	4.13e-05	0.000564	CcSEcCtD
Nicardipine—Dermatitis—Metformin—type 2 diabetes mellitus	4.13e-05	0.000564	CcSEcCtD
Nicardipine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.11e-05	0.000562	CcSEcCtD
Nicardipine—Headache—Metformin—type 2 diabetes mellitus	4.11e-05	0.000561	CcSEcCtD
Nicardipine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000559	CcSEcCtD
Nicardipine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000557	CcSEcCtD
Nicardipine—Diarrhoea—Losartan—type 2 diabetes mellitus	3.98e-05	0.000544	CcSEcCtD
Nicardipine—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000539	CcSEcCtD
Nicardipine—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.95e-05	0.000539	CcSEcCtD
Nicardipine—Vomiting—Irbesartan—type 2 diabetes mellitus	3.93e-05	0.000537	CcSEcCtD
Nicardipine—Rash—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000533	CcSEcCtD
Nicardipine—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.9e-05	0.000532	CcSEcCtD
Nicardipine—Nausea—Metformin—type 2 diabetes mellitus	3.89e-05	0.000532	CcSEcCtD
Nicardipine—Headache—Irbesartan—type 2 diabetes mellitus	3.87e-05	0.000529	CcSEcCtD
Nicardipine—Dizziness—Losartan—type 2 diabetes mellitus	3.85e-05	0.000526	CcSEcCtD
Nicardipine—Vomiting—Losartan—type 2 diabetes mellitus	3.7e-05	0.000506	CcSEcCtD
Nicardipine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.68e-05	0.000502	CcSEcCtD
Nicardipine—Nausea—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000502	CcSEcCtD
Nicardipine—Rash—Losartan—type 2 diabetes mellitus	3.67e-05	0.000501	CcSEcCtD
Nicardipine—Dermatitis—Losartan—type 2 diabetes mellitus	3.67e-05	0.000501	CcSEcCtD
Nicardipine—Headache—Losartan—type 2 diabetes mellitus	3.65e-05	0.000498	CcSEcCtD
Nicardipine—Asthenia—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000489	CcSEcCtD
Nicardipine—Nausea—Losartan—type 2 diabetes mellitus	3.46e-05	0.000472	CcSEcCtD
Nicardipine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000466	CcSEcCtD
Nicardipine—Dizziness—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000451	CcSEcCtD
Nicardipine—Vomiting—Ramipril—type 2 diabetes mellitus	3.17e-05	0.000433	CcSEcCtD
Nicardipine—Rash—Ramipril—type 2 diabetes mellitus	3.15e-05	0.00043	CcSEcCtD
Nicardipine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000429	CcSEcCtD
Nicardipine—Headache—Ramipril—type 2 diabetes mellitus	3.13e-05	0.000427	CcSEcCtD
Nicardipine—Nausea—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000405	CcSEcCtD
Nicardipine—CALM2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.59e-07	9.45e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.59e-07	9.45e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—NOS3—type 2 diabetes mellitus	6.59e-07	9.45e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—NOS3—type 2 diabetes mellitus	6.59e-07	9.45e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	6.57e-07	9.42e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.57e-07	9.42e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.56e-07	9.41e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.56e-07	9.41e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.56e-07	9.41e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—SRC—type 2 diabetes mellitus	6.52e-07	9.35e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	6.52e-07	9.35e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—INS—type 2 diabetes mellitus	6.49e-07	9.32e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	6.49e-07	9.31e-06	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.48e-07	9.3e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	6.46e-07	9.27e-06	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.46e-07	9.26e-06	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—AKT1—type 2 diabetes mellitus	6.46e-07	9.26e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.45e-07	9.26e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.45e-07	9.26e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	6.44e-07	9.23e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.42e-07	9.21e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.42e-07	9.21e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	6.42e-07	9.21e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.41e-07	9.19e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	6.4e-07	9.19e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	6.4e-07	9.18e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.39e-07	9.17e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.38e-07	9.15e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	6.36e-07	9.13e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	6.34e-07	9.1e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	6.32e-07	9.07e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—SRC—type 2 diabetes mellitus	6.3e-07	9.04e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—SRC—type 2 diabetes mellitus	6.3e-07	9.04e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.28e-07	9.01e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—INS—type 2 diabetes mellitus	6.28e-07	9.01e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—INS—type 2 diabetes mellitus	6.28e-07	9.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.28e-07	9.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.28e-07	9e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	6.27e-07	8.99e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	6.26e-07	8.98e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.25e-07	8.97e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—type 2 diabetes mellitus	6.23e-07	8.94e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	6.19e-07	8.89e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.18e-07	8.87e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.18e-07	8.87e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	6.15e-07	8.82e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.08e-07	8.72e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.08e-07	8.72e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.07e-07	8.71e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.07e-07	8.71e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.07e-07	8.7e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.05e-07	8.67e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.05e-07	8.67e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	6.03e-07	8.65e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—type 2 diabetes mellitus	6.03e-07	8.64e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—type 2 diabetes mellitus	6.03e-07	8.64e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.03e-07	8.64e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—SRC—type 2 diabetes mellitus	6.02e-07	8.63e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6e-07	8.61e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	6e-07	8.61e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.97e-07	8.56e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	5.93e-07	8.5e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	5.93e-07	8.5e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.91e-07	8.47e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	5.89e-07	8.44e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.89e-07	8.44e-06	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.85e-07	8.39e-06	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.83e-07	8.36e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—SRC—type 2 diabetes mellitus	5.82e-07	8.35e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—SRC—type 2 diabetes mellitus	5.82e-07	8.35e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.79e-07	8.31e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.78e-07	8.28e-06	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.77e-07	8.28e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.77e-07	8.28e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.77e-07	8.28e-06	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.76e-07	8.26e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.76e-07	8.26e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.74e-07	8.23e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.72e-07	8.2e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—type 2 diabetes mellitus	5.71e-07	8.19e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.7e-07	8.18e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.7e-07	8.17e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.7e-07	8.17e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.68e-07	8.15e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.67e-07	8.13e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	5.66e-07	8.11e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	5.61e-07	8.04e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.59e-07	8.03e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.56e-07	7.98e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.56e-07	7.98e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	5.55e-07	7.96e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.54e-07	7.94e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	5.53e-07	7.93e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—type 2 diabetes mellitus	5.53e-07	7.93e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—type 2 diabetes mellitus	5.53e-07	7.93e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.51e-07	7.9e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.51e-07	7.9e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.51e-07	7.9e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.51e-07	7.9e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	5.5e-07	7.89e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.48e-07	7.85e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.46e-07	7.84e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.46e-07	7.83e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.45e-07	7.82e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.42e-07	7.77e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.42e-07	7.77e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.41e-07	7.75e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.4e-07	7.75e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	5.4e-07	7.74e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.39e-07	7.73e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—type 2 diabetes mellitus	5.38e-07	7.71e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—RELA—type 2 diabetes mellitus	5.36e-07	7.69e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.35e-07	7.67e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.33e-07	7.65e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.31e-07	7.62e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.3e-07	7.61e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.29e-07	7.59e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	5.29e-07	7.59e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	5.29e-07	7.59e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—type 2 diabetes mellitus	5.27e-07	7.56e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.24e-07	7.52e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.23e-07	7.5e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—type 2 diabetes mellitus	5.2e-07	7.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—type 2 diabetes mellitus	5.2e-07	7.46e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.19e-07	7.44e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—RELA—type 2 diabetes mellitus	5.19e-07	7.44e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	5.16e-07	7.4e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.16e-07	7.4e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.16e-07	7.4e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—type 2 diabetes mellitus	5.1e-07	7.32e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—type 2 diabetes mellitus	5.1e-07	7.32e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	5.09e-07	7.29e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.06e-07	7.26e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.05e-07	7.24e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	5.04e-07	7.23e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	5.04e-07	7.23e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	5.03e-07	7.22e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5e-07	7.17e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.98e-07	7.15e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.97e-07	7.13e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.96e-07	7.11e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.94e-07	7.09e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.92e-07	7.05e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.9e-07	7.03e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.9e-07	7.03e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	4.86e-07	6.98e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	4.86e-07	6.98e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.85e-07	6.96e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.84e-07	6.94e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	4.84e-07	6.94e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.84e-07	6.94e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	4.83e-07	6.93e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	4.82e-07	6.92e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	4.82e-07	6.92e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.81e-07	6.9e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.8e-07	6.89e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.75e-07	6.82e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	4.72e-07	6.77e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.68e-07	6.71e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.68e-07	6.71e-06	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.65e-07	6.67e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.65e-07	6.67e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.65e-07	6.67e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.57e-07	6.55e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.56e-07	6.54e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL6—type 2 diabetes mellitus	4.54e-07	6.51e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.52e-07	6.49e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.51e-07	6.47e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.5e-07	6.45e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.47e-07	6.42e-06	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.46e-07	6.39e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.45e-07	6.39e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	4.45e-07	6.38e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.44e-07	6.37e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.43e-07	6.36e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.42e-07	6.35e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.42e-07	6.34e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.42e-07	6.34e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	4.41e-07	6.33e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.41e-07	6.33e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—type 2 diabetes mellitus	4.39e-07	6.3e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.37e-07	6.27e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.37e-07	6.27e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.37e-07	6.27e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.36e-07	6.25e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.33e-07	6.21e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.29e-07	6.15e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.29e-07	6.15e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.26e-07	6.11e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—type 2 diabetes mellitus	4.25e-07	6.09e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—type 2 diabetes mellitus	4.25e-07	6.09e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.25e-07	6.09e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—type 2 diabetes mellitus	4.21e-07	6.04e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.2e-07	6.02e-06	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.19e-07	6.01e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.1e-07	5.89e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—type 2 diabetes mellitus	4.08e-07	5.85e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.08e-07	5.85e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—type 2 diabetes mellitus	4.05e-07	5.81e-06	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—type 2 diabetes mellitus	4.05e-07	5.81e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.97e-07	5.69e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.97e-07	5.69e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—type 2 diabetes mellitus	3.92e-07	5.62e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—type 2 diabetes mellitus	3.92e-07	5.62e-06	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—type 2 diabetes mellitus	3.92e-07	5.62e-06	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—type 2 diabetes mellitus	3.92e-07	5.62e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.77e-07	5.41e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.77e-07	5.4e-06	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	3.74e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—type 2 diabetes mellitus	3.74e-07	5.36e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.7e-07	5.3e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.69e-07	5.3e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.64e-07	5.23e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.64e-07	5.23e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.63e-07	5.2e-06	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—type 2 diabetes mellitus	3.62e-07	5.19e-06	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—type 2 diabetes mellitus	3.62e-07	5.19e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.57e-07	5.12e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.57e-07	5.12e-06	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.48e-07	4.99e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.4e-07	4.88e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	3.39e-07	4.86e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.36e-07	4.81e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	3.35e-07	4.8e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.32e-07	4.77e-06	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	3.22e-07	4.61e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.18e-07	4.56e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.18e-07	4.56e-06	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	3.15e-07	4.52e-06	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	3.14e-07	4.51e-06	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.14e-07	4.5e-06	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—type 2 diabetes mellitus	3.13e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.13e-07	4.49e-06	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.1e-07	4.44e-06	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.09e-07	4.43e-06	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—type 2 diabetes mellitus	3.03e-07	4.34e-06	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—type 2 diabetes mellitus	3.03e-07	4.34e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.91e-07	4.17e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.84e-07	4.07e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.75e-07	3.94e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.75e-07	3.94e-06	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-07	3.91e-06	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.62e-07	3.76e-06	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.53e-07	3.63e-06	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.53e-07	3.63e-06	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	2.43e-07	3.49e-06	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-07	3.4e-06	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	2.24e-07	3.21e-06	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	2.22e-07	3.18e-06	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.46e-07	2.1e-06	CbGpPWpGaD
